No Data
No Data
No Data
Biome Australia Logs 74% Revenue Increase in Fiscal Q3
Biome Australia (ASX:BIO) logged AU$3.2 million in revenue in the fiscal third quarter ended March 31, a 74% jump from the same period a year prior, according to a Thursday filing with the Australian
Biome Australia Logs First Positive Underlying Quarterly Cash Flow in Fiscal Q3
Biome Australia (ASX:BIO) posted its first positive underlying quarterly cash flow in the third quarter of fiscal 2024, the microbiome health company said in a Tuesday filing with the Australian Secur
Biome Australia to Launch Into UK and Ireland Health Retail Markets
Biome Australia (ASX:BIO) has started delivering its first allocation of Activated Probiotics into pharmacy and health retail stores across the United Kingdom and the Republic of Ireland.
Biome's Activated Probiotics Enters UK, Ireland; Shares Jump 10%
Microbiome health company Biome Australia (ASX:BIO) has delivered its first allocation of Activated Probiotics into UK and Republic of Ireland pharmacy and health retail stores following the signing o
Biome Australia Lifts FY24 Revenue Guidance to $12.5m
Specialist live biotherapeutics health company Biome Australia (ASX: BIO) has significantly increased its full year revenue guidance to $12.5 million, boosted by better-than-expected sales in recent months.
Biome Reports Surge in Half Year Sales Revenue
Biome Australia (ASX:BIO) said it recorded unaudited sales revenue of approximately AU$6 million for the first half of FY24 and unaudited sales revenue of approximately AU$3.3 million for the second q
No Data